Skip to main content
NUWE logo

NUWE · Nuwellis, Inc. · Metrics

Track NUWE — free
$0.69 -0.06 (-7.37%) At close · Oct 2
Market Cap
$2.83M
Shares
3.65M
Volume · Oct 2 108.5K Avg daily vol (3M) 4.34M

NUWE metrics

53 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.69
Market cap
$2.83M

Price action

20 metrics
Price change (1W)
-10.6%
Price change (30D)
-5.6%
Price change (3M)
-78.0%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
312.8%
Annualized volatility (3M)
322.4%
Beta
—
RSI (14D)
36.6
Price vs SMA 50
-41.5%
Price vs SMA 200
—
Avg volume (3M)
4.34M
Relative volume
0.0
Average dollar volume
$11.61M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
3.65M

Valuation

12 metrics
P / E (TTM)
0.0
Trailing earnings · reciprocal yield 310,579.4%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.3×
reciprocal yield 318.5%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-400.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
69.7%
Operating margin
-142.9%
Trailing 12 months
Net margin
-125.6%
Gross profit (TTM)
$6.28M
Operating profit (TTM)
−$12.88M
Net income (TTM)
−$11.32M
Trailing 12 months
Diluted EPS (TTM)
$2,154.80
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1,908.88

Growth

11 metrics
Revenue growth YoY
+14.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$9.01M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2,981.8%
Year over year · more shares
Revenue CAGR (3Y)
-1.1%
Revenue CAGR (5Y)
+2.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-124.1%
Debt / equity
—
Current ratio
2.0
EBITDA (TTM)
−$12.72M
Free cash flow (TTM)
—
Quick ratio
1.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$3.92M
Total assets
$9.13M
Total debt
$5.90M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$12.46M
Capital expenditures (TTM)
$125,000
R&D (TTM)
$4.16M
SG&A (TTM)
$15.00M
Stock compensation (TTM)
$90,000
R&D / revenue
46.1%
Stock compensation / revenue
1.0%

Ownership (13F)

3 metrics
13F filers
5
13F filer change QoQ
-3
Institutional ownership
0.6%

Short interest

3 metrics
Short interest
1.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
30 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1506492 CUSIP 67113Y801 Visit website Investor relations